Skip to main content

Yidu Tech Inc. (2158.HK)

Hong Kong Stock Exchange Healthcare Medical - Healthcare Information ServicesView data quality →
41.2Fair

ValueMarkers Composite Index

Top 8%#41,138 of 44,707

DCF data not available

Piotroski
1/9
Weak
Beneish
-2.35
Low Risk
Altman
3.05
Safe
DCF Value
-
N/A
ROIC
-4.6%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Yidu Tech Inc. (2158.HK) — VMCI valuation read

Composite valuation read on 2158.HK: VMCI 41/100 against a Healthcare sector median of 50. The 9-point below-median print is the headline number for Yidu Tech Inc., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for 2158.HK: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on 2158.HK: 2158.HK trades at 27.0x earnings, 50% above the Healthcare median of 18.0x; ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp; net debt to EBITDA of -1.1x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

2158.HK rose 1.4% over the trailing 7 days, with a -17.4% read on a 30-day basis.

Yidu Tech Inc. provides healthcare solutions built on big data and artificial intelligence technologies in Mainland China, Brunei, and internationally. The company operates through Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and Others segments. The Big Data Platform and Solutions segment offers data intelligence platforms and data analytics-driven solutions to hospitals, other healthcare institutions, regulators, and policy makers. This segment also provides applications and solutions to hospitals focusing on research, clinical diagnosis and treatment, and hospital operations management; DPAP/Eywa platforms for hospitals and medical institutions; and intelligent research and clinical and management solutions to medical customers. The Life Sciences Solutions segment offers analytics-driven clinical development, real-world evidence (RWE)-based research, and digital commercialization solutions to pharmaceutical, biotech, medical device, and other companies. The Health Management Platform and Solutions segment provides health management platform application and solution services; and insurance technology and solutions to insurance companies, agencies, and related regulators and policy makers. This segment also engages in the distribution of insurance companies products; and sale of pharmaceutical products and related hardware and other services. The Others segment is involved in the sale of computer hardware. The company also engages in the sale of medical devices; insurance brokerage activities; and medical and computer technology development activities. Yidu Tech Inc. was incorporated in 2014 and is headquartered in Beijing, China.

CEO: Jiming Xu866 employeesCNwww.yidutechgroup.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 2158.HK’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.